-
Je něco špatně v tomto záznamu ?
Human-Centered Design Strategies for Device Selection in mHealth Programs: Development of a Novel Framework and Case Study
AM. Polhemus, J. Novák, J. Ferrao, S. Simblett, M. Radaelli, P. Locatelli, F. Matcham, M. Kerz, J. Weyer, P. Burke, V. Huang, MF. Dockendorf, G. Temesi, T. Wykes, G. Comi, I. Myin-Germeys, A. Folarin, R. Dobson, NV. Manyakov, VA. Narayan, M. Hotopf
Jazyk angličtina Země Kanada
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
171
Alzheimer's Society - United Kingdom
G0901434
Medical Research Council - United Kingdom
MC_PC_17214
Medical Research Council - United Kingdom
NLK
Directory of Open Access Journals
od 2013
Free Medical Journals
od 2013
PubMed Central
od 2013
Europe PubMed Central
od 2013
ProQuest Central
od 2013-01-01
Open Access Digital Library
od 2013-01-01
Open Access Digital Library
od 2013-01-01
Health & Medicine (ProQuest)
od 2013-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2013
PubMed
32379055
DOI
10.2196/16043
Knihovny.cz E-zdroje
- MeSH
- lidé MeSH
- technologie MeSH
- telemedicína * MeSH
- zdravotnický personál MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: Despite the increasing use of remote measurement technologies (RMT) such as wearables or biosensors in health care programs, challenges associated with selecting and implementing these technologies persist. Many health care programs that use RMT rely on commercially available, "off-the-shelf" devices to collect patient data. However, validation of these devices is sparse, the technology landscape is constantly changing, relative benefits between device options are often unclear, and research on patient and health care provider preferences is often lacking. OBJECTIVE: To address these common challenges, we propose a novel device selection framework extrapolated from human-centered design principles, which are commonly used in de novo digital health product design. We then present a case study in which we used the framework to identify, test, select, and implement off-the-shelf devices for the Remote Assessment of Disease and Relapse-Central Nervous System (RADAR-CNS) consortium, a research program using RMT to study central nervous system disease progression. METHODS: The RADAR-CNS device selection framework describes a human-centered approach to device selection for mobile health programs. The framework guides study designers through stakeholder engagement, technology landscaping, rapid proof of concept testing, and creative problem solving to develop device selection criteria and a robust implementation strategy. It also describes a method for considering compromises when tensions between stakeholder needs occur. RESULTS: The framework successfully guided device selection for the RADAR-CNS study on relapse in multiple sclerosis. In the initial stage, we engaged a multidisciplinary team of patients, health care professionals, researchers, and technologists to identify our primary device-related goals. We desired regular home-based measurements of gait, balance, fatigue, heart rate, and sleep over the course of the study. However, devices and measurement methods had to be user friendly, secure, and able to produce high quality data. In the second stage, we iteratively refined our strategy and selected devices based on technological and regulatory constraints, user feedback, and research goals. At several points, we used this method to devise compromises that addressed conflicting stakeholder needs. We then implemented a feedback mechanism into the study to gather lessons about devices to improve future versions of the RADAR-CNS program. CONCLUSIONS: The RADAR device selection framework provides a structured yet flexible approach to device selection for health care programs and can be used to systematically approach complex decisions that require teams to consider patient experiences alongside scientific priorities and logistical, technical, or regulatory constraints.
Department of Engineering and Applied Science University of Bergamo Bergamo Italy
Epidemiology Biostatistics and Prevention Institute University of Zürich Zürich Switzerland
Institute of Psychiatry Psychology and Neuroscience King's College London London United Kingdom
Janssen Pharmaceutica NV Beerse Belgium
Merck Research Labs Information Technology Merck Sharpe and Dohme Prague Czech Republic
Merck Research Labs Information Technology Merck Sharpe and Dohme Singapore Singapore
Neurology Services San Raffaele Hospital Multiple Sclerosis Centre Milan Italy
Pharmacokinetics Pharmacodynamics and Drug Metabolism Merck and Co Inc Kenilworth NJ United States
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21012605
- 003
- CZ-PrNML
- 005
- 20210713152743.0
- 007
- ta
- 008
- 210420s2020 xxc f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2196/16043 $2 doi
- 035 __
- $a (PubMed)32379055
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxc
- 100 1_
- $a Polhemus, Ashley Marie $u Merck Research Labs Information Technology, Merck Sharpe & Dohme, Prague, Czech Republic ; Epidemiology, Biostatistics and Prevention Institute, University of Zürich, Zürich, Switzerland
- 245 10
- $a Human-Centered Design Strategies for Device Selection in mHealth Programs: Development of a Novel Framework and Case Study / $c AM. Polhemus, J. Novák, J. Ferrao, S. Simblett, M. Radaelli, P. Locatelli, F. Matcham, M. Kerz, J. Weyer, P. Burke, V. Huang, MF. Dockendorf, G. Temesi, T. Wykes, G. Comi, I. Myin-Germeys, A. Folarin, R. Dobson, NV. Manyakov, VA. Narayan, M. Hotopf
- 520 9_
- $a BACKGROUND: Despite the increasing use of remote measurement technologies (RMT) such as wearables or biosensors in health care programs, challenges associated with selecting and implementing these technologies persist. Many health care programs that use RMT rely on commercially available, "off-the-shelf" devices to collect patient data. However, validation of these devices is sparse, the technology landscape is constantly changing, relative benefits between device options are often unclear, and research on patient and health care provider preferences is often lacking. OBJECTIVE: To address these common challenges, we propose a novel device selection framework extrapolated from human-centered design principles, which are commonly used in de novo digital health product design. We then present a case study in which we used the framework to identify, test, select, and implement off-the-shelf devices for the Remote Assessment of Disease and Relapse-Central Nervous System (RADAR-CNS) consortium, a research program using RMT to study central nervous system disease progression. METHODS: The RADAR-CNS device selection framework describes a human-centered approach to device selection for mobile health programs. The framework guides study designers through stakeholder engagement, technology landscaping, rapid proof of concept testing, and creative problem solving to develop device selection criteria and a robust implementation strategy. It also describes a method for considering compromises when tensions between stakeholder needs occur. RESULTS: The framework successfully guided device selection for the RADAR-CNS study on relapse in multiple sclerosis. In the initial stage, we engaged a multidisciplinary team of patients, health care professionals, researchers, and technologists to identify our primary device-related goals. We desired regular home-based measurements of gait, balance, fatigue, heart rate, and sleep over the course of the study. However, devices and measurement methods had to be user friendly, secure, and able to produce high quality data. In the second stage, we iteratively refined our strategy and selected devices based on technological and regulatory constraints, user feedback, and research goals. At several points, we used this method to devise compromises that addressed conflicting stakeholder needs. We then implemented a feedback mechanism into the study to gather lessons about devices to improve future versions of the RADAR-CNS program. CONCLUSIONS: The RADAR device selection framework provides a structured yet flexible approach to device selection for health care programs and can be used to systematically approach complex decisions that require teams to consider patient experiences alongside scientific priorities and logistical, technical, or regulatory constraints.
- 650 _2
- $a zdravotnický personál $7 D006282
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a technologie $7 D013672
- 650 12
- $a telemedicína $7 D017216
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Novák, Jan $u Merck Research Labs Information Technology, Merck Sharpe & Dohme, Prague, Czech Republic ; Department of Anthropology and Human Genetics, Faculty of Science, Charles University, Prague, Czech Republic
- 700 1_
- $a Ferrao, Jose $u Merck Research Labs Information Technology, Merck Sharpe & Dohme, Prague, Czech Republic
- 700 1_
- $a Simblett, Sara $u Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom
- 700 1_
- $a Radaelli, Marta $u Neurology Services, San Raffaele Hospital Multiple Sclerosis Centre, Milan, Italy
- 700 1_
- $a Locatelli, Patrick $u Department of Engineering and Applied Science, University of Bergamo, Bergamo, Italy
- 700 1_
- $a Matcham, Faith $u Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom ; National Institute for Health Research, Maudsley Biomedical Research Centre, South London and Maudsley NHS Foundation Trust, London, United Kingdom
- 700 1_
- $a Kerz, Maximilian $u Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom
- 700 1_
- $a Weyer, Janice $u Patient Advisory Board, Remote Assessment of Disease and Relapse Research Program, King's College London, London, United Kingdom
- 700 1_
- $a Burke, Patrick $u Patient Advisory Board, Remote Assessment of Disease and Relapse Research Program, King's College London, London, United Kingdom
- 700 1_
- $a Huang, Vincy $u Merck Research Labs Information Technology, Merck Sharpe & Dohme, Singapore, Singapore
- 700 1_
- $a Dockendorf, Marissa Fallon $u Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Merck & Co, Inc, Kenilworth, NJ, United States
- 700 1_
- $a Temesi, Gergely $u Merck Research Labs Information Technology, Merck Sharpe & Dohme, Prague, Czech Republic
- 700 1_
- $a Wykes, Til $u Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom $u National Institute for Health Research, Maudsley Biomedical Research Centre, South London and Maudsley NHS Foundation Trust, London, United Kingdom
- 700 1_
- $a Comi, Giancarlo $u Neurology Services, San Raffaele Hospital Multiple Sclerosis Centre, Milan, Italy
- 700 1_
- $a Myin-Germeys, Inez $u Department for Neurosciences, Center for Contextual Psychiatry, Katholieke Universiteit Leuven, Leuven, Belgium
- 700 1_
- $a Folarin, Amos $u Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom $u National Institute for Health Research, Maudsley Biomedical Research Centre, South London and Maudsley NHS Foundation Trust, London, United Kingdom
- 700 1_
- $a Dobson, Richard $u Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom
- 700 1_
- $a Manyakov, Nikolay V $u Janssen Pharmaceutica NV, Beerse, Belgium
- 700 1_
- $a Narayan, Vaibhav A $u Research and Development Information Technology, Janssen Research & Development, LLC, Titusville, NJ, United States
- 700 1_
- $a Hotopf, Matthew $u Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom $u National Institute for Health Research, Maudsley Biomedical Research Centre, South London and Maudsley NHS Foundation Trust, London, United Kingdom
- 773 0_
- $w MED00198720 $t JMIR mHealth and uHealth $x 2291-5222 $g Roč. 8, č. 5 (2020), s. e16043
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32379055 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210713152740 $b ABA008
- 999 __
- $a ok $b bmc $g 1650882 $s 1132984
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 8 $c 5 $d e16043 $e 20200507 $i 2291-5222 $m JMIR mHealth and uHealth $n JMIR Mhealth Uhealth $x MED00198720
- GRA __
- $a 171 $p Alzheimer's Society $2 United Kingdom
- GRA __
- $a G0901434 $p Medical Research Council $2 United Kingdom
- GRA __
- $a MC_PC_17214 $p Medical Research Council $2 United Kingdom
- LZP __
- $a Pubmed-20210420